SMART Program for Paroxysmal Atrial Fibrillation
This is a pilot study to test the effects of the SMART-3RP (Stress Management and Resiliency Training Relaxation Response Resiliency Program) on quality of life, mental health, arrhythmia burden, and heart rate variability (HRV) in patients with paroxysmal atrial fibrillation (PAF).
Study Start Date
February, 23 2018
Estimated Completion Date
- Other: SMART Program
Massachusetts General Hospital -- 2018P000015
Massachusetts General Hospital
- Diagnosed with documented recurrent symptomatic PAF.
- Currently on stable medical therapy for AF and willing to continue on the same treatment regimen while participating in the study.
- No current daily practice of yoga, meditation, guided imagery or other techniques that elicit the RR.
- Able to provide informed consent and to understand written and spoken English.
- Allergy to adhesives that prevents wearing the HRV monitor.
- Patients unable or unwilling to participate in an intervention delivered via video conferencing.
- End Stage renal failure or heart failure, severe unstable medical or psychiatric disease.
- Patients deemed unable to complete protocol due to cognitive or other reasons.
- Patients on psychoactive medications will have eligibility determined by the PI or MD co-investigator on a case-by-case basis, and will be admitted to the study if medication is deemed stable
18 Years to 90 Years
Accepts Healthy Volunteers
Study Locations and Contact Information (1)
|Massachusetts General Hospital - Boston, Massachusetts||2.8 miles||Gillian Gadennefirstname.lastname@example.org|